Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study

被引：0

作者：

Nagai, T. ^{[1
]}

Nakanishi, N. ^{[1
]}

Yamashita, Y. ^{[2
]}

Muraoka, N. ^{[3
]}

Umetsu, M. ^{[4
]}

Nishimoto, Y. ^{[5
]}

Takada, T. ^{[6
]}

Ogihara, Y. ^{[7
]}

Nishikawa, T. ^{[7
]}

Ikeda, N. ^{[8
]}

Otsui, K. ^{[9
]}

Sueta, D. ^{[10
]}

Tsubata, Y. ^{[11
]}

Shoji, M. ^{[12
]}

Matoba, S. ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Kyoto, Japan

[2] Kyoto Univ, Cardiovasc Med, Kyoto, Japan

[3] Shizuoka Canc Ctr, Cardiol, Shizuoka, Japan

[4] Tohoku Univ Hosp, Vasc Surg, Sendai, Miyagi, Japan

[5] Osaka Gen Med Ctr, Cardiol, Osaka, Japan

[6] Tokyo Womens Med Univ, Cardiol, Tokyo, Japan

[7] Mie Univ, Cardiol & Nephrol, Grad Sch Med, Tsu, Mie, Japan

[8] Toho Univ, Cardiovasc Med, Ohashi Med Ctr, Tokyo, Japan

[9] Kobe Univ, Internal Med, Kobe, Hyogo, Japan

[10] Kumamoto Univ, Cardiovasc Med, Kumamoto, Japan

[11] Shimane Univ, Fac Med, Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane, Japan

[12] Natl Canc Ctr, Cardiovasc Med, Tokyo, Japan

来源：

EUROPEAN HEART JOURNAL | 2024年 / 45卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[1] Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study
Nagai, T.
Nakanishi, N.
Yamashita, Y.
Muraoka, N.
Umetsu, M.
Nishimoto, Y.
Takada, T.
Ogihara, Y.
Nishikawa, T.
Ikeda, N.
Otsui, K.
Sueta, D.
Tsubata, Y.
Shoji, M.
Matoba, S.
EUROPEAN HEART JOURNAL, 2024, 45
[2] Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial
Yamashita, Yugo
Morimoto, Takeshi
Muraoka, Nao
Oyakawa, Takuya
Umetsu, Michihisa
Akamatsu, Daijirou
Nishimoto, Yuji
Sato, Yukihito
Takada, Takuma
Jujo, Kentaro
Minami, Yuichiro
Ogihara, Yoshito
Dohi, Kaoru
Fujita, Masashi
Nishikawa, Tatsuya
Ikeda, Nobutaka
Hashimoto, Go
Otsui, Kazunori
Mori, Kenta
Sueta, Daisuke
Tsubata, Yukari
Shoji, Masaaki
Shikama, Ayumi
Hosoi, Yutaka
Tanabe, Yasuhiro
Chatani, Ryuki
Tsukahara, Kengo
Nakanishi, Naohiko
Kim, Kitae
Ikeda, Satoshi
Mo, Makoto
Yoshikawa, Yusuke
Kimura, Takeshi
CIRCULATION, 2023, 148 (21) : 1665 - 1676
[3] Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study
Chatani, Ryuki
Yamashita, Yugo
Morimoto, Takeshi
Muraoka, Nao
Umetsu, Michihisa
Nishimoto, Yuji
Takada, Takuma
Ogihara, Yoshito
Nishikawa, Tatsuya
Ikeda, Nobutaka
Otsui, Kazunori
Sueta, Daisuke
Tsubata, Yukari
Shoji, Masaaki
Shikama, Ayumi
Hosoi, Yutaka
Tanabe, Yasuhiro
Tsukahara, Kengo
Nakanishi, Naohiko
Kim, Kitae
Ikeda, Satoshi
Mushiake, Kazunori
Kadota, Kazushige
Ono, Koh
Kimura, Takeshi
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 422 - 431
[4] Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study
Galanaud, J. -P.
Sevestre, M. -A.
Pernod, G.
Genty, C.
Richelet, S.
Kahn, S. R.
Boulon, C.
Terrisse, H.
Quere, I.
Bosson, J. -L.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 907 - 916
[5] The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study
Sueta, Daisuke
Yamashita, Yugo
Morimoto, Takeshi
Muraoka, Nao
Umetsu, Michihisa
Nishimoto, Yuji
Takada, Takuma
Ogihara, Yoshito
Nishikawa, Tatsuya
Ikeda, Nobutaka
Otsui, Kazunori
Tsubata, Yukari
Shoji, Masaaki
Shikama, Ayumi
Hosoi, Yutaka
Tanabe, Yasuhiro
Chatani, Ryuki
Tsukahara, Kengo
Nakanishi, Naohiko
Kim, Kitae
Ikeda, Satoshi
Mo, Makoto
Kimura, Takeshi
Tsujita, Kenichi
THROMBOSIS RESEARCH, 2024, 235 : 107 - 115
[6] Anticoagulation for distal deep venous thrombosis in cancer patients; a post-hoc analysis from PROVE-emboli study
Nose, T.
Imamura, Y.
Ohata, S.
Mori, K.
Otui, K.
Kimbara, S.
Nagatani, Y.
Koyama, T.
Funakoshi, Y.
Kiyota, N.
Minami, H.
ANNALS OF ONCOLOGY, 2024, 35 : S1323 - S1323
[7] EFFICACY OF LONG-TERM TREATMENT WITH DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER ON SLEEP AND DAYTIME FUNCTIONING: A POST-HOC ANALYSIS
Dauvilliers, Y.
Benes, H.
Garcia-Borreguero, D.
Kunz, D.
Plazzi, G.
Thein, S.
Coloma, P.
Rausch, M.
Sassi-Sayadi, M.
Kinter, D. Seboek
SLEEP MEDICINE, 2022, 100 : S119 - S119
[8] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY
Aletaha, D.
Westhovens, R.
Combe, B.
Gottenberg, J. E.
Buch, M. H.
Caporali, R.
Gomez-Puerta, J. A.
Van Hoek, P.
Rajendran, V.
Stiers, P. J.
Hendrikx, T.
Burmester, G. R.
Tanaka, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 612 - 613
[9] Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study
Donadini, Marco P.
Dentali, Francesco
Pegoraro, Samuela
Pomero, Fulvio
Brignone, Chiara
Guasti, Luigina
Steidl, Luigi
Ageno, Walter
VASCULAR MEDICINE, 2017, 22 (06) : 518 - 524
[10] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
Ishigooka, Jun
Inada, Ken
Niidome, Kazunari
Aoki, Kazuo
Kojima, Yoshitsugu
Iwashita, Shuichi
Yamada, Sakiko
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)

← 1 2 3 4 5 →